These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 2413894)

  • 21. Novel properties of human monocyte plasminogen activator.
    Stephens RW; Golder JP
    Eur J Biochem; 1984 Mar; 139(2):253-8. PubMed ID: 6199200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of dexamethasone inhibition of plasminogen activator in rat hepatoma cells.
    Seifert SC; Gelehrter TD
    Proc Natl Acad Sci U S A; 1978 Dec; 75(12):6130-3. PubMed ID: 104300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proenzyme to urokinase-type plasminogen activator in human colon cancer: in vitro inhibition by monocyte minactivin after proteolytic activation.
    Stephens RW; Fordham CJ; Doe WF
    Eur J Cancer Clin Oncol; 1987 Feb; 23(2):213-22. PubMed ID: 2965017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human fibroblasts produce inhibitor directed against plasminogen activator when treated with glucocorticoids.
    Crutchley DJ; Conanan LB; Maynard JR
    Ann N Y Acad Sci; 1981; 370():609-16. PubMed ID: 6455956
    [No Abstract]   [Full Text] [Related]  

  • 25. Expression of the catalytic activity of plasminogen activator under physiologic conditions.
    Aggeler J; Risch J; Werb Z
    Biochim Biophys Acta; 1981 Jun; 675(1):62-8. PubMed ID: 6455162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary fibrin/fibrinogen derivatives.
    Hedner U
    Thromb Diath Haemorrh; 1975 Dec; 34(3):693-708. PubMed ID: 54945
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of plasminogen activator associated with chronic granulomatous inflammation.
    Goldstein SM; Izaki S; Epstein WL
    Thromb Res; 1979; 16(5-6):727-35. PubMed ID: 160627
    [No Abstract]   [Full Text] [Related]  

  • 28. Glucocorticoids inhibit plasminogen activator production by endothelial cells.
    Laug WE
    Thromb Haemost; 1983 Dec; 50(4):888-92. PubMed ID: 6420927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM; Greco WR
    Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A sensitive and specific assay for plasminogen activators.
    Smith DS; Harmon J; Owen WG
    Thromb Res; 1985 Feb; 37(4):533-41. PubMed ID: 4039078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parallel induction of fibrinolysis and receptors for plasminogen and urokinase by interferon gamma on U937 cells.
    Lu H; Mirshahi M; Krief P; Soria C; Soria J; Mishal Z; Bertrand O; Perrot JY; Li H; Picot C
    Biochem Biophys Res Commun; 1988 Aug; 155(1):418-22. PubMed ID: 2843185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human articular cartilage contains an inhibitor of plasminogen activator.
    Yamada H; Stephens RW; Nakagawa T; McNicol D
    J Rheumatol; 1988 Jul; 15(7):1138-43. PubMed ID: 3139880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasminogen activation: biochemistry, physiology, and therapeutics.
    Wun TC
    Crit Rev Biotechnol; 1988; 8(2):131-48. PubMed ID: 2976309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasminogen activators and their inhibitors: regulators of extracellular proteolysis and cell function.
    Hart DA; Rehemtulla A
    Comp Biochem Physiol B; 1988; 90(4):691-708. PubMed ID: 2854764
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of plasminogen activator in ovulation.
    Akazawa K; Matsuo O; Kosugi T; Mihara H; Mori N
    Acta Physiol Lat Am; 1983; 33(2):105-10. PubMed ID: 6422700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural inhibitors of fibrinolysis.
    Collen D
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():24-30. PubMed ID: 6448870
    [No Abstract]   [Full Text] [Related]  

  • 39. Isolation of peptides with anti-urokinase activity from the human placenta.
    Uszynski M
    Thromb Haemost; 1980 Feb; 42(5):1411-6. PubMed ID: 6768150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The irreversible inhibition of urokinase, kidney-cell plasminogen activator, plasmin and beta-trypsin by 1-(N-6-amino-n-hexyl)carbamoylimidazole.
    Walker B; Elmore DT
    Biochem J; 1984 Jul; 221(1):277-80. PubMed ID: 6235806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.